SOTIO Presents Overview of DUET-01 Phase 1/2 Study at ASCO Annual Meeting
• Patient enrollment and dosing ongoing in first-in-human study of BOXR1030 enhanced CAR T-cell therapy;
SOTIO Biotech, a clinical-stage immuno-oncology company owned by PPF Group, will present on June 1, 2024 (Developmental Therapeutics—Immunotherapy session) a Trial-in-Progress poster on the first-in-human DUET-01 Phase 1/2 study at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting. The study is evaluating the use of BOXR1030, a metabolically enhanced CAR T-cell therapy, for the treatment of patients with solid tumors.
SOTIO to Present Poster on DUET-01 Clinical Trial at 2024 ASCO Annual Meeting
SOTIO Biotech, a clinical-stage immuno-oncology company owned by PPF Group, today announced it will present a Trial-in-Progress poster on the DUET-01 Phase 1/2 study of BOXR1030 at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting taking place May 31 – June 4, 2024, in Chicago, IL.
SOTIO Shares New Preclinical Data on BOXR Platform of Enhanced T Cell Therapies at AACR Annual Meeting
- BOXR data support platform’s ability to improve on CAR T-cell therapy’s efficacy in solid tumor models;
- Additional poster investigates utility of PARP inhibitors in combination with immune checkpoint inhibitors
SOTIO Biotech, a clinical-stage immuno-oncology company owned by PPF Group, today presented new preclinical data from the Company’s BOXR platform of enhanced T cell therapies, as well as mechanistic research into the immunostimulatory effects of PARP inhibitors, at the 2024 American Association for Cancer Research (AACR) Annual Meeting.
SOTIO Biotech B.V.
Strawinskylaan 933
1077XX Amsterdam
Netherlands
Strawinskylaan 933
1077XX Amsterdam
Netherlands
SOTIO Biotech a.s.
Českomoravská 2532/19b
190 00 Prague 9
Czech Republic
Českomoravská 2532/19b
190 00 Prague 9
Czech Republic
SOTIO Biotech AG
Lichtstrasse 35 - WSJ-210
4056 Basel
Switzerland
Lichtstrasse 35 - WSJ-210
4056 Basel
Switzerland
SOTIO Biotech Inc.
180 Canal St., Suite 300
Boston, MA 02114
USA
180 Canal St., Suite 300
Boston, MA 02114
USA
Term of use
Data protection
Cookies Policy
Cookie settings
Clinical Trials Privacy Notice
© 2013 - 2024 Sotio
Sitemap
Terms of Use and Privacy
© 2013 - 2024 Sotio